Published in Sci Rep on April 11, 2017
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2014) 2.39
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet (2015) 1.34
Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14 463 cases and 44 188 controls. Carcinogenesis (2016) 0.77
A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer. Sci Rep (2016) 0.77
Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep (2017) 0.75
Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog (2017) 0.75
Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. Mol Carcinog (2016) 0.75
Genetic Variants in the Genes Encoding Rho GTPases and Related Regulators Predict Cutaneous Melanoma-specific Survival. Int J Cancer (2017) 0.75
A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signaling. Sci Rep (2017) 0.75
Reduced mRNA Expression of Nucleotide Excision Repair Genes in Lymphocytes and Risk of Squamous Cell Carcinoma of the Head and Neck. Carcinogenesis (2017) 0.75
A PGC1β genetic variant associated with nevus count and melanoma mortality. Int J Cancer (2017) 0.75
Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis (2017) 0.75
Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer (2017) 0.75
Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy. Lung Cancer (2017) 0.75
Novel Genetic Variants in the P38MAPK Pathway Gene ZAK and Susceptibility to Lung Cancer. Mol Carcinog (2017) 0.75